Benzinga (Thu, 28-Mar 2:08 PM ET)
Options Volatility and Implied Earnings Moves Today, March 28, 2024
TipRanks (Thu, 28-Mar 8:05 AM ET)
22nd Century GAAP EPS of -$0.66, revenue of $7.36M
Seeking Alpha News (Thu, 28-Mar 6:09 AM ET)
22nd Century Q4 Earnings Preview
Seeking Alpha News (Wed, 27-Mar 11:37 AM ET)
Notable earnings before Thursday's open
Seeking Alpha News (Wed, 27-Mar 9:11 AM ET)
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
TipRanks (Mon, 25-Mar 8:00 AM ET)
Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more
Seeking Alpha News (Sun, 24-Mar 8:01 AM ET)
Presenting on the Emerging Growth Conference 67 Day 2 on February 8 Register Now
Globe Newswire (Wed, 7-Feb 7:00 AM ET)
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has two operating segments; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain 95% less nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM, and The hemp/cannabis segment is engaged in providing hemp-derived cannabinoid ingredients and API, as well as a CDMO to the consumer goods industry. It derives a majority of its revenue from the tobacco segment.
22Nd Century Group trades on the NASDAQ stock market under the symbol XXII.
As of March 28, 2024, XXII stock price declined to $0.12 with 2,428,574 million shares trading.
XXII has a beta of 1.74, meaning it tends to be more sensitive to market movements. XXII has a correlation of 0.02 to the broad based SPY ETF.
XXII has a market cap of $5.25 million. This is considered a Sub-Micro Cap stock.
Last quarter 22Nd Century Group reported $18 million in Revenue and -$.78 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.13.
In the last 3 years, XXII stock traded as high as $91.05 and as low as $.10.
The top ETF exchange traded funds that XXII belongs to (by Net Assets): VXF, MJ, VTI.
XXII has underperformed the market in the last year with a price return of -98.9% while the SPY ETF gained +33.6%. XXII has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -35.3% and -10.8%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
XXII support price is $.12 and resistance is $.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XXII stock will trade within this expected range on the day.